Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 6, 2009

Broad Institute to Use Genedata’s Small Molecule Screener

  • The Broad Institute of Harvard and MIT has adopted Genedata’s Screener® for small molecule screening. The Screener will be used in the institute’s contribution to the Molecular Libraries and Imaging Initiative funded by the NIH. This NIH program for medical research, composed of nine institutions, conducts high-throughput biological studies of diverse small molecules to advance new drug discoveries.

    Researchers at the Broad Institute are using Screener’s Assay Analyzer and Condoseo modules. Assay Analyzer captures data from diverse plate readers and processes them based on predefined business rules. Condoseo fits dose-response curves for IC50 determination in validation and assay panel screens.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »